Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid-induced remission
- 1 March 1980
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 78 (3), 518-523
- https://doi.org/10.1016/0016-5085(80)90866-5
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Chronic Hepatitis: To Treat or Not to Treat?Medical Clinics of North America, 1978
- Severe chronic active liver diseaseDigestive Diseases and Sciences, 1977
- HLA Determinants in Chronic Active Liver Disease: Possible Relation of HLA‐Dw3 to PrognosisTissue Antigens, 1977
- Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.Gut, 1976
- FAILURE OF CUSTOMARY TREATMENT IN CHRONIC ACTIVE LIVER-DISEASE - CAUSES AND MANAGEMENT1976
- Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared.Gut, 1975
- Genetic analysis of patients with chronic active hepatitis.Journal of Clinical Investigation, 1975
- CONTROLLED TRIAL OF PREDNISONE AND AZATHIOPRINE IN ACTIVE CHRONIC HEPATITISThe Lancet, 1973
- Clinical, Biochemical, and Histological Remission of Severe Chronic Active Liver Disease: A Controlled Study of Treatments and Early PrognosisGastroenterology, 1972
- Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsyDigestive Diseases and Sciences, 1971